title: Stromedix acquisition signals growing interest in fibrosis.
authors.forename: Malorye
authors.initials: M
authors.lastname: Allison
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000276:immunology; D035843:Biomedical Research / Q000191:economics* / Q000639:trends; D001709:Biotechnology / Q000191:economics* / Q000639:trends; D003132:Commerce; D005060:Europe; D005355:Fibrosis / Q000188:drug therapy*; D006801:Humans; D016023:Integrins / Q000276:immunology; D008168:Lung / Q000187:drug effects; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D016023:Integrins; C073878:integrin alphavbeta6